Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited treatment options and poor prognosis. Carbon ion radiotherapy (CIRT) has emerged as a promising treatment modality for HCC due to its unique physical and biological properties. CIRT uses carbon ions to target and destroy cancer cells with a high precision and efficacy. The Bragg Peak phenomenon allows precise dose delivery to the tumor while minimizing damage to healthy tissues. In addition, the high relative biological effectiveness of carbon ions can be shown against radioresistant and hypoxic tumor areas. CIRT also offers a shorter treatment schedule than conventional radiotherapy, which increases patient convenience and compliance. The clinical outcomes of CIRT for HCC have shown excellent local control rates with minimal side effects. Considering its physical and biological properties, CIRT may be a viable option for complex clinical scenarios such as patients with poor liver function, large tumors, re-irradiation cases, and tumors close to critical organs. Further research and larger studies are needed to establish definitive indications for CIRT and to compare its efficacy with that of other treatment modalities. Nevertheless, CIRT offers a potential breakthrough in HCC management, providing hope for improved therapeutic outcomes and reduced treatment-related toxicities.
Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto Annals of Surgical Oncology.2025; 32(2): 1073. CrossRef
Tumor‐Targeted Catalytic Immunotherapy En‐Li Yang, Wu‐Yin Wang, Ying‐Qi Liu, Hong Yi, Aiwen Lei, Zhi‐Jun Sun Advanced Materials.2025;[Epub] CrossRef
Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing 99 mTc-GSA scintigraphy prior to carbon-ion radiotherapy Kana Yamazaki, Tatsuya Higashi, Ryuichi Nishii, Tamasa Terada, Yoichi Mizutani, Yuki Ogura, Mana Akamatsu, Toshitaka Kuroiwa, Hirokazu Makishima, Masaru Wakatsuki, Hitoshi Ishikawa Annals of Nuclear Medicine.2025; 39(8): 781. CrossRef
Study on the application of multislice spiral CT in the diagnosis and evaluation of radiotherapy efficacy for esophageal cancer W. Huang, L. Wang, H. Ye International Journal of Radiation Research.2025; 23(1): 121. CrossRef
Cost-Effectiveness of Carbon Ion Radiotherapy in Oncology: A Systematic Review Abdulrahman Bin Sumaida, Nandan M Shanbhag, Khalifa AlKaabi, Khalid Balaraj Cureus.2025;[Epub] CrossRef
First report of metabolic complete response in hepatic sarcomatoid carcinoma achieved with carbon-ion radiotherapy Ryu Takakura, Yoshiyuki Ota, Yuki Yamazaki, Satoru Iwamoto, Koki Kurouchi, Koki Moriyoshi, Shin’ichi Miyamoto Clinical Journal of Gastroenterology.2025; 18(5): 879. CrossRef
Advances in radiotherapy for mouth neoplasms: emerging technologies and future perspectives Xuhong Liu, Zhuoya Zhang, Xinyu Deng, Zekun Lang, Jianrong Wang Discover Oncology.2025;[Epub] CrossRef
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study Keita Maki, Hiroaki Haga, Tomohiro Katsumi, Kyoko Hoshikawa, Fumiya Suzuki, Fumi Uchiyama, Takashi Kaneko, Masashi Koto, Yoshiyuki Ueno Cancers.2025; 17(15): 2542. CrossRef
Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan Keita Maki, Hiroaki Haga, Tomohiro Katsumi, Kyoko Hoshikawa, Takashi Kaneko, Ryosuke Takahashi, Shuichiro Sugawara, Masashi Koto, Fuyuhiko Motoi, Yoshiyuki Ueno Journal of Clinical Medicine.2025; 14(16): 5678. CrossRef
Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects: A Narrative Review Reina Sasaki-Tanaka, Hiroyuki Abe, Tomoaki Yoshida, Yusuke Watanabe, Naruhiro Kimura, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Kenya Kamimura, Tatsuo Kanda, Shuji Terai Journal of Clinical Medicine.2025; 14(17): 6107. CrossRef
Carbon-ion radiotherapy induces ferroptosis and M1 macrophage polarization to inhibit the development of gastric cancer by downregulating DHODH Yue Wang, Hongyi Cai Frontiers in Medicine.2025;[Epub] CrossRef
A multi‐modal diffusion model for noise reduction of particle number limited Monte Carlo dose calculation for carbon ion radiotherapy Jueye Zhang, Youfang Lai, Haonan Feng, Xiangde Luo, Kai‐Wen Li, Tenghui Wang, Cheng Chang, Gen Yang, Chen Lin, Tian Li, Chao Yang, Yibao Zhang Medical Physics.2025;[Epub] CrossRef
Targeting gut microbiota and metabolites in cancer radiotherapy Shuling Ma, Xinpei Li, Shijie Shang, Zijun Zhai, Meng Wu, Qian Song, Dawei Chen Clinical and Translational Medicine.2025;[Epub] CrossRef
Potential applications of metal-based nanomaterials in tumor radiotherapy: from x-ray to particle therapies Yingxin Liu, Butuo Li, Linlin Wang Cancer Nanotechnology.2025;[Epub] CrossRef
The research perspectives and frontiers on radiotherapy for hepatocellular carcinoma: a bibliometric analysis and systematic review Tao He, Hong Xiao, Bin Yi, Chengyan Zhou, Juan Yang, Ke Sun, Jieyu Zou Frontiers in Oncology.2025;[Epub] CrossRef
Metronidazole-modified Au@BSA nanocomposites for dual sensitization of radiotherapy in solid tumors Qijun Du, Ho-Yin Yuen, Jingke Pan, Chenwei Sun, Di Wu, Jie Liu, Guohua Wu, Xin Zhao, Shuqi Wang Journal of Materials Chemistry B.2024; 12(38): 9686. CrossRef
Value of Carbon-Ion Radiation Therapy for Breast Cancer Bowen Yu, Kai-Wen Li, Yingyi Fan, Xiaohua Pei International Journal of Particle Therapy.2024; 14: 100629. CrossRef
Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy Lokesh Seth, Kevin L. Stephans Hepatoma Research.2024;[Epub] CrossRef
Mechanisms of Cancer Cell Radioresistance: Modern Trends and Research Prospects M. G Sharapov, E. E Karmanova, S. V Gudkov Biofizika.2024; 69(6): 1235. CrossRef
Mechanisms of Cancer Cell Radioresistance: Modern Trends and Research Prospects M. G. Sharapov, E. E. Karmanova, S. V. Gudkov Biophysics.2024; 69(6): 1064. CrossRef
Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics Guangyuan Zhang, Zhenshan Zhang, Yulei Pei, Wei Hu, Yushan Xue, Renli Ning, Xiaomao Guo, Yun Sun, Qing Zhang Frontiers in Endocrinology.2023;[Epub] CrossRef
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy Sang Min Yoon Clinical and Molecular Hepatology.2023; 29(4): 977. CrossRef
Pencil Beam Scanning Carbon Ion Radiotherapy for Hepatocellular Carcinoma Wenna Zhang, Xin Cai, Jiayao Sun, Weiwei Wang, Jingfang Zhao, Qing Zhang, Guoliang Jiang, Zheng Wang Journal of Hepatocellular Carcinoma.2023; Volume 10: 2397. CrossRef
With increasing clinical use, radiotherapy (RT) has been considered reliable and effective method for hepatocellular carcinoma (HCC) treatment, depending on extent of disease and patient characteristics. RT for HCC can improve therapeutic outcomes through excellent local control, downstaging, conversion from unresectable to resectable status, and treatments of unresectable HCCs with vessel invasion or multiple intrahepatic metastases. In addition, further development of modern RT technologies, including image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy, has expanded the indication of RT. An essential feature of IGRT is that it allows image guidance therapy through in-room images obtained during radiation delivery. Compared with 3D-conformal RT, distinctions of IMRT are inverse treatment planning process and use of a large number of treatment fields or subfields, which provide high precision and exquisitely conformal dose distribution. These modern RT techniques allow more precise treatment by reducing inter- and intra-fractional errors resulting from daily changes and irradiated dose at surrounding normal tissues. More recently, particle therapy has been actively investigated to improve effectiveness of RT. This review discusses modern RT strategies for HCC, as well as optimal selection of RT in multimodal approach for HCC.
Citations
Citations to this article as recorded by
The Rac1-USP11 feedback amplification loop: a radiation-activated engine driving radioresistance in hepatocellular carcinoma Kaixiao Zhou, Yabo Jiang, Jiahao Guo, Haobo Zhang, Yuhao Hu, Xuanyu Meng, Yecheng Li, Shaohua Wei, Jian Wang, Xubiao Wei, Shuqun Cheng, Jianping Cao, Yang Jiao British Journal of Cancer.2026; 134(3): 391. CrossRef
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis Changcheng Tao, Liguo Liu, Nan Hu, Hongwei Wang, Kai Zhang, Yue Liu, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu Journal of Hepatocellular Carcinoma.2025; Volume 12: 261. CrossRef
Microenvironment-triggered copper peroxide and tannic acid cooperatively iron-coordinated nanocomposites for oxidative stress-enhanced radiotherapy of hepatocellular carcinoma Zipeng Lei, Jiaqi Liao, Huiqin Yao, Xiaoting Zhou, Chun Yang, Qihui Wang, Hailong Jin, Xiao He, Qing Zhang, Yan Zu Nano Today.2025; 63: 102771. CrossRef
Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024 Deepti Ravi, Shahid Ahmed, Blaire Anderson, Brady Anderson, Bryan Brunet, Haji Chalchal, Arun Elangovan, Georgia Geller, Vallerie Gordon, Branawan Gowrishankar, Edward Hardy, Mussawar Iqbal, Duc Le, Richard Lee-Ying, Shazia Mahmood, Karen Mulder, Maged Na Current Oncology.2025; 32(7): 398. CrossRef
Effects of three-dimensional conformal radiotherapy and image-guided radiotherapy on patients with liver cancer F. Xu, P. Xu International Journal of Radiation Research.2025; 23(3): 563. CrossRef
Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma Hye In Lee, Jinhong Jung, So Yeon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon International Journal of Radiation Oncology*Biology*Physics.2025;[Epub] CrossRef
A review of deep learning approaches for multimodal image segmentation of liver cancer Chaopeng Wu, Qiyao Chen, Haoyu Wang, Yu Guan, Zhangyang Mian, Cong Huang, Changli Ruan, Qibin Song, Hao Jiang, Jinghui Pan, Xiangpan Li Journal of Applied Clinical Medical Physics.2024;[Epub] CrossRef
Dual-doped metalloporphyrin MOFs-based nanoagent increases low-dose radiotherapy efficacy by apoptosis-ferroptosis for hepatocellular carcinoma Xinxin Wang, Jianmin Zhou, Yanlin Zhu, Can Yu, Di Sun, Yuanfei Yao, Lili Feng, Piaoping Yang, Yang Zhou Chemical Engineering Journal.2024; 501: 157645. CrossRef
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat-Moghadam, Maryam Zamani Sani, Mohammad Taghizadeh, Effat Alizadeh Clinical and Experimental Medicine.2024;[Epub] CrossRef
Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy Si-Tong Wang, Yi-Xing Chen, Yu-Nan Gao, Ping Yang, Qian-Qian Zhao, Zhao-Chong Zeng, Yuan Zhuang Hepatoma Research.2024;[Epub] CrossRef
Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial–Mesenchymal Transition and Metastasis Yueh-Shan Weng, I-Tsang Chiang, Jai-Jen Tsai, Yu-Chang Liu, Fei-Ting Hsu International Journal of Radiation Oncology*Biology*Physics.2023; 115(3): 719. CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Radionuclide‐Labeled Microspheres for Radio‐Immunotherapy of Hepatocellular Carcinoma Sai Yang, Chongjing Mu, Teng Liu, Pei Pei, Wenhao Shen, Yanxiang Zhang, Guanglin Wang, Lei Chen, Kai Yang Advanced Healthcare Materials.2023;[Epub] CrossRef
Advances in radiotherapy and immunity in hepatocellular carcinoma Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li Journal of Translational Medicine.2023;[Epub] CrossRef
Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma Hwa Kyung Byun, Changhwan Kim, Jinsil Seong Clinical and Molecular Hepatology.2023; 29(4): 945. CrossRef
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Myung Ji Goh, Hee Chul Park, Jeong Il Yu, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Dong Hyun Sinn, Moon Seok Choi Liver Cancer.2023; 12(5): 467. CrossRef
Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy Bardia Bidarmaghz, Marwan Idrees, Yoo Young Lee, Peter Hodgkinson BMJ Case Reports.2023; 16(12): e256931. CrossRef
MiR-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin G1 Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge International Journal of Radiation Biology.2022; 98(1): 11. CrossRef
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Jina Kim, Hwa Kyung Byun, Tae Hyung Kim, Sun Il Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Jinsil Seong Cancers.2022; 14(10): 2396. CrossRef
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study Jian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, Xiao-Feng Lin, Mei-Ying Long, Jie Zhang, Ting-Shi Su, Li-Qing Li, Ya-Dan Pang, Chun-Feng Liang, Hong-Mei Zhou, Hai-Yan Lu, Shi-Xiong Liang, Bang-De Xiang Radiation Oncology.2022;[Epub] CrossRef
The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy Ying Xu, Yi Yang, Lu Li, Feng Ye, Xinming Zhao Frontiers in Oncology.2022;[Epub] CrossRef
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2022; 23(12): 1126. CrossRef
External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis Han Li, Zhenying Wu, Jiali Chen, Ke Su, Lu Guo, Ke Xu, Tao Gu, Yi Jiang, Pan Wang, Hao Zeng, Hao Chi, Kun He, Yunwei Han Clinical and Experimental Medicine.2022; 23(5): 1537. CrossRef
Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study Nalee Kim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Zhao Chong Zeng, Victor H.F. Lee, Chul Seung Kay, Jinsil Seong International Journal of Radiation Oncology*Biology*Physics.2021; 109(2): 464. CrossRef
Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Hwa Kyung Byun, Nalee Kim, Jinsil Seong Yonsei Medical Journal.2021; 62(5): 409. CrossRef
PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair Yinghai Xie, Changwei Liu, Yinci Zhang, Amin Li, Chong Sun, Rui Li, Yingru Xing, Minghong Shi, Qi Wang, Yi-Hsien Hsieh PLOS ONE.2021; 16(10): e0258817. CrossRef
Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways Yinghai Xie, Changwei Liu, Shuping Zhou, Qi Wang, Xiaolong Tang Journal of Biomedical Nanotechnology.2021; 17(11): 2247. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases Chang Liu, Yu‐Li Wang, Yong‐Yu Yang, Ning‐Ping Zhang, Chen Niu, Xi‐Zhong Shen, Jian Wu The FASEB Journal.2021;[Epub] CrossRef
MR-Guided Radiotherapy for Liver Malignancies Luca Boldrini, Stefanie Corradini, Cihan Gani, Lauren Henke, Ali Hosni, Angela Romano, Laura Dawson Frontiers in Oncology.2021;[Epub] CrossRef
ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM Hua Ren, Zhi-cheng Wei, Yan-xia Sun, Chun-yan Qiu, Wen-jue Zhang, Wei Zhang, Tao Liu, Xu Che Frontiers in Oncology.2021;[Epub] CrossRef
KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo Zhenya Gao, Huanxia Jia, Fang Yu, Hongfang Guo, Baoyu Li Experimental and Therapeutic Medicine.2021;[Epub] CrossRef
Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing Apoptosis Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge Radiation Research.2021;[Epub] CrossRef
Delayed response to proton beam treatment of hepatocellular carcinoma Chee-Wai Cheng, Mitchell Machtay, Jennifer Dorth, Olga Sergeeva, Hangsheng Xia, chawan manaspon, Hanping wu, Renuka Iyer, Sandra Sexton, Wei Xin, Agata A Exner, Zhenghong Lee BJR|case reports.2020; 6(1): 20180125. CrossRef
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma Nalee Kim, Jason Cheng, Inkyung Jung, Ja Der Liang, Yu Lueng Shih, Wen-Yen Huang, Tomoki Kimura, Victor H.F. Lee, Zhao Chong Zeng, Ren Zhenggan, Chul Seung Kay, Seok Jae Heo, Jong Yoon Won, Jinsil Seong Journal of Hepatology.2020; 73(1): 121. CrossRef
Circular RNA TUBD1 Acts as the miR-146a-5p Sponge to Affect the Viability and Pro-Inflammatory Cytokine Production of LX-2 Cells through the TLR4 Pathway Hao Niu, Li Zhang, Yu-Han Chen, Bao-Ying Yuan, Zhi-Feng Wu, Jason Chia-Hsien Cheng, Qin Lin, Zhao-Chong Zeng Radiation Research.2020; 193(4): 383. CrossRef
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2020; 12(9): 2527. CrossRef
Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy Kyung In Shin, Byoung Kuk Jang, Jin Hee Kim, Jae Seok Hwang Journal of Liver Cancer.2020; 20(2): 167. CrossRef
Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry Young Eun Chon, Han Ah Lee, Jun Sik Yoon, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Eunyang Kim, Young-Joo Won, Jeong-Hoon Lee Journal of Liver Cancer.2020; 20(2): 135. CrossRef
External beam radiation therapy in a centenarian with primary liver cancer Zhen Meng, Feifei Gao, Chang Liu, Shengcai Huang, Kai Hu, Rensheng Wang Medicine.2020; 99(47): e22473. CrossRef
Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma Hwa Kyung Byun, Nalee Kim, Sangjoon Park, Jinsil Seong Strahlentherapie und Onkologie.2019; 195(11): 1007. CrossRef
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation Chang Gon Kim, Hyun Woong Lee, Hye Jin Choi, Jung Il Lee, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Han Sang Kim, Kyung Hwan Kim, Seong Jin Choi, Yongun Kim, Kwan Sik Lee, Gyoung Min Kim, Man Deuk Kim, Jong Yoo Cancer Medicine.2019; 8(11): 5023. CrossRef
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C Yeon Joo Kim, Jinhong Jung, Ji Hyeon Joo, So Yeon Kim, Jin Hyoung Kim, Young-Suk Lim, Han Chu Lee, Jong Hoon Kim, Sang Min Yoon Radiotherapy and Oncology.2019; 141: 95. CrossRef
Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, Hee Chul Park, Kwang Cheol Koh Journal of Liver Cancer.2019; 19(2): 136. CrossRef
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee PLOS ONE.2019; 14(10): e0223678. CrossRef
Knockdown of interferon‑stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin Baoxiang Chen, Shuqiang Jin, Bin Bai, Zhi Li, Caifang Ni, Yansen Liu Experimental and Therapeutic Medicine.2019;[Epub] CrossRef
Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Marwa G. El-Gazzar, Mostafa G.M. El-Gazzar Bioorganic & Medicinal Chemistry Letters.2018; 28(9): 1464. CrossRef
Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature Yi-Lan Lin World Journal of Hepatology.2018; 10(10): 772. CrossRef
First
Prev
